Literature DB >> 7802634

Role of HDL apolipoprotein E in cellular cholesterol efflux: studies in apo E knockout transgenic mice.

T Hayek1, J Oiknine, J G Brook, M Aviram.   

Abstract

The role of apo E in aspects of reverse cholesterol transport was studied in apolipoprotein E-deficient mice. These animals develop rampant atherosclerosis. The efflux of cholesterol from mouse peritoneal macrophages (MPM) was 40% lower when induced by high density lipoprotein (HDL) from apo E-deficient mice, compared to the effect of HDL from normal mice. On adding apo E to apo E-deficient HDL, cholesterol efflux from the macrophages increased by 35%, approaching the degree of efflux obtained with normal HDL. This HDL (normal or apo E-deficient)-induced cholesterol efflux was similar in peritoneal macrophages derived from both normal and apo E-deficient mice, suggesting that the HDL apo E rather than the macrophage apo E is responsible for the stimulation of cellular cholesterol efflux. On determining cholesterol efflux specifically from the macrophage plasma membrane, the level of efflux was similar for both HDL preparations, suggesting that apo E in HDL is important for cholesterol translocation to the plasma membrane, the initial step in reverse cholesterol transport. It is concluded that the enhanced atherosclerosis in apo E-deficient mice could be related, at least partly, to the impaired efflux of LDL derived cholesterol from macrophages of the arterial wall.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7802634     DOI: 10.1006/bbrc.1994.2775

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  16 in total

Review 1.  Role of plasma phospholipid transfer protein in lipid and lipoprotein metabolism.

Authors:  John J Albers; Simona Vuletic; Marian C Cheung
Journal:  Biochim Biophys Acta       Date:  2011-06-28

2.  ApoE influences amyloid-β (Aβ) clearance despite minimal apoE/Aβ association in physiological conditions.

Authors:  Philip B Verghese; Joseph M Castellano; Kanchan Garai; Yinong Wang; Hong Jiang; Aarti Shah; Guojun Bu; Carl Frieden; David M Holtzman
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-25       Impact factor: 11.205

Review 3.  The key role of apolipoprotein E in atherosclerosis.

Authors:  Kirsty Greenow; Nigel J Pearce; Dipak P Ramji
Journal:  J Mol Med (Berl)       Date:  2005-04-13       Impact factor: 4.599

4.  Proteomic profiling following immunoaffinity capture of high-density lipoprotein: association of acute-phase proteins and complement factors with proinflammatory high-density lipoprotein in rheumatoid arthritis.

Authors:  Junji Watanabe; Christina Charles-Schoeman; Yunan Miao; David Elashoff; Yuen Yin Lee; George Katselis; Terry D Lee; Srinivasa T Reddy
Journal:  Arthritis Rheum       Date:  2012-01-09

5.  Macrophage-specific expression of human apolipoprotein E reduces atherosclerosis in hypercholesterolemic apolipoprotein E-null mice.

Authors:  S Bellosta; R W Mahley; D A Sanan; J Murata; D L Newland; J M Taylor; R E Pitas
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

6.  Hsa-miRNA-23a-3p promotes atherogenesis in a novel mouse model of atherosclerosis.

Authors:  Jiayan Guo; Hanbing Mei; Zhen Sheng; Qingyuan Meng; Murielle M Véniant; Hong Yin
Journal:  J Lipid Res       Date:  2020-10-02       Impact factor: 5.922

7.  Hemoglobin and its scavenger protein haptoglobin associate with apoA-1-containing particles and influence the inflammatory properties and function of high density lipoprotein.

Authors:  Junji Watanabe; Victor Grijalva; Susan Hama; Karen Barbour; Franklin G Berger; Mohamad Navab; Alan M Fogelman; Srinivasa T Reddy
Journal:  J Biol Chem       Date:  2009-05-11       Impact factor: 5.157

8.  A novel anti-atherogenic role for COX-2--potential mechanism for the cardiovascular side effects of COX-2 inhibitors.

Authors:  Ajay Narasimha; Junji Watanabe; James A Lin; Susan Hama; Robert Langenbach; Mohamad Navab; Alan M Fogelman; Srinivasa T Reddy
Journal:  Prostaglandins Other Lipid Mediat       Date:  2007-03-14       Impact factor: 3.072

9.  Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein.

Authors:  Shubhendu Sen Roy; Huy Cong Xuan Nguyen; Thomas A Angelovich; Anna C Hearps; Diana Huynh; Anthony Jaworowski; Theodoros Kelesidis
Journal:  J Vis Exp       Date:  2017-10-12       Impact factor: 1.355

10.  Low-dose expression of a human apolipoprotein E transgene in macrophages restores cholesterol efflux capacity of apolipoprotein E-deficient mouse plasma.

Authors:  Y Zhu; S Bellosta; C Langer; F Bernini; R E Pitas; R W Mahley; G Assmann; A von Eckardstein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.